Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Tumor Malignancy or Hematologic Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00321581
What this trial is testing

AZD2171 to Treat Children and Adolescents With Solid Tumors or Acute Myelogenous Leukemia

Who this might be right for
Refractory or Recurrent Solid TumorsAcute Myelogenous Leukemia
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT01618136
What this trial is testing

An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors

Who this might be right for
Malignant Solid TumourOvarian CancerTriple Negative Breast Cancer+2 more
Eisai Limited 41
Testing effectiveness (Phase 2)Study completedNCT02034981
What this trial is testing

Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK, MET or ROS1

Who this might be right for
Hematologic CancersSolid TumorsMetastatic Cancer
UNICANCER 246
Early research (Phase 1)Study completedNCT00124605
What this trial is testing

Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 24
Not applicableUnknownNCT04743388
What this trial is testing

Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System

Who this might be right for
COVID-19Healthy VolunteersChronic Disease+2 more
National and Kapodistrian University of Athens 600
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439266
What this trial is testing

Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT03678883
What this trial is testing

9-ING-41 in Patients With Advanced Cancers

Who this might be right for
CancerPancreatic CancerSarcoma+22 more
Actuate Therapeutics Inc. 350
Early research (Phase 1)Study completedNCT04944888
What this trial is testing

GSL Synthetase Inhibitor in Combination With Immune Checkpoint Inhibitor in Previously Treated Blood and Solid Tumor

Who this might be right for
Solid TumorHematologic Malignancy
Chinese PLA General Hospital 31
Testing effectiveness (Phase 2)Study completedNCT02419417
What this trial is testing

Study of BMS-986158 in Subjects With Select Advanced Cancers

Who this might be right for
Advanced Tumors
Bristol-Myers Squibb 83
Early research (Phase 1)Study completedNCT00019513
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas

Who this might be right for
Colorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+7 more
National Institutes of Health Clinical Center (CC) 108
Testing effectiveness (Phase 2)Looking for participantsNCT06395103
What this trial is testing

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaDiffuse Large B-cell LymphomaBurkitt Lymphoma+2 more
Merck Sharp & Dohme LLC 90
Early research (Phase 1)Study completedNCT00045500
What this trial is testing

UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT01912222
What this trial is testing

Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction

Who this might be right for
Advanced Solid TumorsHematologic Malignancies
Millennium Pharmaceuticals, Inc. 48
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Testing effectiveness (Phase 2)Study completedNCT01831726
What this trial is testing

Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib

Who this might be right for
Tumor Pathway Activations Inhibited by Dovitinib
Novartis Pharmaceuticals 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439149
What this trial is testing

Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Genetic Changes (MATCH-Subprotocol N)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT01284348
What this trial is testing

To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer

Who this might be right for
AnemiaCarcinoma, Non-Small-Cell LungCarcinoma, Small-Cell Lung+3 more
Merck Sharp & Dohme LLC 26
Early research (Phase 1)Study completedNCT00458731
What this trial is testing

Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+59 more
National Cancer Institute (NCI) 57
Not applicableStudy completedNCT00445731
What this trial is testing

A Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow Transplant

Who this might be right for
Cancer
University of Minnesota 115
Early research (Phase 1)Study completedNCT01457417
What this trial is testing

DKN-01 in Multiple Myeloma or Advanced Solid Tumors

Who this might be right for
Multiple MyelomaSolid TumorsNon-Small Cell Lung Cancer
Leap Therapeutics, Inc. 32
Next Page